BRKR - Bruker Corporation
NEXT EARNINGS:
May 6, 2026
EPS Est: $0.26
|
Rev Est: $793.1M
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$52.13
DETAILS
HIGH:
$60.00
LOW:
$35.00
MEDIAN:
$52.50
CONSENSUS:
$52.13
UPSIDE:
31.08%
Market Cap:
6.04B
Volume:
2,100,539
Avg Volume:
2,380,516
52 Week Range:
28.53-56.22
Sector:
Healthcare
Industry:
Medical - Devices
Beta:
1.18
Last Dividend:
$0.20
Exchange:
NASDAQ
Country:
US
Employees:
11,396
IPO Date:
2000-08-04
EPS (TTM):
-0.15
P/E Ratio:
-831.55
Revenue (TTM):
3.44B
Total Assets:
6.24B
Total Debt:
1.87B
Cash & Equiv:
298.80M
Rev Growth (5Y):
11.6%
EPS Growth (5Y):
-9.8%
FCF Growth (5Y):
-28.7%
ROCE:
4.4%
Debt/Equity:
0.76
Earnings History
| Date | EPS Actual | EPS Est | EPS Surprise | Rev Actual | Rev Est | Rev Surprise |
|---|---|---|---|---|---|---|
| 2026-02-12 | $0.59 | $0.65 | -9.2% | $977.2M | $799.1M | +22.3% |
| 2025-11-03 | $0.60 | $0.33 | +81.8% | $860.5M | $964.6M | -10.8% |
| 2025-08-04 | $0.32 | $0.33 | -3.0% | $797.4M | $810.2M | -1.6% |
| 2025-05-07 | $0.47 | $0.46 | +2.2% | $801.4M | $819.9M | -2.3% |
| 2025-02-13 | $0.76 | $0.75 | +1.3% | $979.6M | $965.6M | +1.4% |
| 2024-11-05 | $0.60 | $0.61 | -1.6% | $864.4M | $859.4M | +0.6% |
| 2024-08-06 | $0.52 | $0.52 | 0.0% | $800.7M | $796.5M | +0.5% |
| 2024-05-02 | $0.53 | $0.46 | +15.2% | $721.7M | $729.9M | -1.1% |
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 3.44B | 3.37B | 2.96B | 2.53B | 2.42B | 1.99B | 2.07B | 1.90B | 1.77B | 1.61B | 1.62B | 1.81B |
| Net Income | (8.60M) | 113.10M | 427.20M | 296.60M | 277.10M | 157.80M | 197.20M | 179.70M | 78.60M | 153.60M | 101.60M | 56.70M |
| EPS | -0.15 | 0.76 | 2.92 | 2.00 | 1.83 | 1.03 | 1.27 | 1.15 | 0.50 | 0.95 | 0.60 | 0.34 |
| Total Assets | 6.24B | 5.81B | 4.25B | 3.61B | 3.65B | 3.05B | 2.77B | 2.13B | 1.95B | 1.81B | 1.73B | 1.86B |
| Total Debt | 1.87B | 2.25B | 1.38B | 1.27B | 1.39B | 912.80M | 880.90M | 341.10M | 415.60M | 411.70M | 266.70M | 355.00M |
| Cash & Equivalents | 298.80M | 183.40M | 488.30M | 645.50M | 1.07B | 681.80M | 678.30M | 322.40M | 325.00M | 342.40M | 267.10M | 319.50M |
| Operating Cash Flow | 134.10M | 251.30M | 350.10M | 274.40M | 282.40M | 332.20M | 213.40M | 239.70M | 154.40M | 130.80M | 229.20M | 114.30M |
| Free Cash Flow | 43.30M | 136.00M | 243.20M | 145.20M | 190.40M | 235.00M | 140.40M | 190.50M | 110.70M | 93.70M | 195.00M | 80.50M |
| FCF per Share | 0.29 | 0.91 | 1.66 | 0.98 | 1.26 | 1.53 | 0.90 | 1.22 | 0.70 | 0.58 | 1.16 | 0.48 |
| Book Value | 2.47B | 1.78B | 1.38B | 1.11B | 1.07B | 961.20M | 906.80M | 905.10M | 733.50M | 693.10M | 732.90M | 771.70M |
| Cash & ST Investments | 298.80M | 183.40M | 488.30M | 645.50M | 1.17B | 731.80M | 684.90M | 322.40M | 439.20M | 500.30M | 468.30M | 497.50M |
| ROC Equity | -0.00 | 0.06 | 0.31 | 0.27 | 0.26 | 0.16 | 0.22 | 0.20 | 0.11 | 0.22 | 0.14 | 0.07 |